Mondéjar BMD

Language: Spanish
References: 11
Page: 1-7
PDF size: 363.29 Kb.

ABSTRACT

Introduction: Vaginal candidiasis is a frequent gynecological disease in women, 40% of them evolve to chronicity, being in these cases recurrent and resistant to usual treatments which produces a negative impact on their quality of life.
Objective: Evaluate the effectiveness of ozone therapy in a patient with recurrent vaginal candidiasis resistant to conventional pharmacological treatment.
Methods: Data were obtained from medical history. A pre-treatment study was indicated, it was detected in direct vaginal swab and positive culture of Candida albicans and elevated glucose. Medicinal ozone was administered from the Azur Trujillo Ozone Center by vaginal insufflation and ozonated oil on the vulva for 20 sessions. In addition, the patient´s partner was given ozonated oil. Diabetes mellitus was diagnosed which was treated with metformin (tablet 850 mg), 1 tablet after breakfast and dinner.
Results: At the end of the treatment there was total resolution of the clinical picture and the direct vaginal swab and culture were negative; glucose was normalized.
Conclusions: Ozone therapy is an alternative treatment for recurrent vaginal candidiasis, which is why it is recommended to carry out other studies with a greater number of patients.

REFERENCES

1. Pineda J, Cortés AA, Uribarren T, Castañón LR. Candidosis vaginal. Revisión de laliteratura y situación de México y otros países latinoamericanos. Rev med Risaralda. 2017[acceso 12/04/2022];23(1). Disponible en:http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0122-06672017000100009&lng=en

2. Ugalde González F, Rivera Gutierrez H, Durán Méndez MJ. Candidiasis vulvovaginalrecurrente. Rev méd sinerg. 2021 [acceso 02/02/2022];6(9):e700. Disponible en:https://revistamedicasinergia.com/index.php/rms/article/view/700

3. Barraza NL, Ayala F, Izaguirre H, Luna A, Carranza C. Características clínicas devulvovaginitis por Cándida Albicans en mujeres en edad reproductiva. Rev Peru InvestigMatern Perinat. 2019;8(1):8-12. DOI: 10.33421/inmp.2019133

4. Sobell J, Mitchell C. Candida vulvovaginitis: Clinical manifestations and diagnosis.Uptodate.com. 2020 [acceso 05/05/2021]. Disponible en:https://www.uptodate.com/contents/candida-vulvovaginitis-clinical-manifestations-anddiagnosis

5. Schwartz A. Ozonoterapia en el tratamiento de la vulvo-vaginitis recurrente por Candidaalbicans. Revista Española de Ozonoterapia. 2015 [acceso 12/04/2022];5(1):89-97.Disponible en: https://dialnet.unirioja.es/descarga/articulo/5095044.pdf

6. Bocci V. Ozone: A new medical drug. Netherlands: Springer; 2010.

7. Schwartz A, Martínez G. Ozone therapy and its Scientific Foundations. Revista Españolade Ozonoterapia. 2012 [acceso 12/04/2022];2(1):121-39. Disponible en:https://dialnet.unirioja.es/descarga/articulo/5506701.pdf

8. Urgellés S, López O, Álvarez M, Reyes E. Ozonoterapia en pacientes con dolor pélvicocrónico. Rev Cub Med Mil. 2021 [acceso 12/04/2022];50(3). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572021000300020&lng=es

9. Nogales CG, Ferreira MB, Lage JL, Antoniazzi JH. Comparison of the antimicrobialactivity of three different concentrations of aqueous ozone on Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis-in vitro study. Revista Española deOzonoterapia. 2014 [acceso 12/04/2022];4(1):9-15. Disponible en:https://dialnet.unirioja.es/descarga/articulo/4828947.pdf

10. Urgelles SA, Aguilar L, Reyes E, Álvarez M. Uso de ozonoterapia en las pacientes conenfermedad inflamatoria pélvica aguda Etapa III. Rev Cubana Obstet Ginecol. 2019[12/04/2022];45(3). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2019000300005&lng=es

11. Menassa A. El ozono en ginecología. Rev Vivo Sano. 2019 [acceso 12/04/2022];24.Disponible en: https://www.vivosano.org/el-ozono-en-ginecologia/